Calypso Biotech
is a Netherlands-based biotechnology company that researches and develops monoclonal antibodies for the treatment of autoimmune diseases... Read moreCalypso Biotech
is a Netherlands-based biotechnology company that researches and develops monoclonal antibodies for the treatment of autoimmune diseases... Read more
News
Jan 10, 2024
Pulse2.0
Calypso Biotech: Novartis Acquiring Calypso: Details About The Deal
Dec 15, 2022
B3C Group
Press Release: Calypso Biotech : Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis
Sep 20, 2021
startupticker
Calypso Biotech: Clinical progression and 8M funding for Calypso Biotech
Nov 16, 2020
FinanzNachrichten
Calypso Biotech BV: DGAP-News: CALYPSO BIOTECH SA: Calypso Biotech announces successful dosing of first Phase 1 cohort with anti-Interleukin-15 (IL-15) monoclonal antibody CALY-002 for the treatment of Autoimmune Diseases
Jun 18, 2020
Contract Pharma
Calypso: Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
Feb 26, 2019
startupticker
Calypso Biotech: String of successes for Merck Serono spin-offs
Feb 22, 2019
Manufacturing Chemist
Calypso Biotech: CALY-002 antibody: AGC and Calypso team up on manufacture process
Feb 20, 2019
Contract Pharma
Calypso Biotech: AGC, Calypso Form Devt./Mfg. Deal
Calypso Biotech Competitors
1
2
3
4
5
6
7
8
9
10